VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
872
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
174
Interactions with Platform & by Email
PARTICIPANTS
33
Unique # Participated
VALIDATIONS
16
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
165
PAGES
239
EDITION
8
PRICE
USD $4950
The World of Cancer/Tumor Profiling is Changing Fast!
It's Time to Identify Upcoming Revenue Pockets & Growth Areas.
Amid the COVID-19 crisis, the global market for Cancer/Tumor Profiling estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$11.6 Billion by 2027, growing at a CAGR of 9.3% over the analysis period 2020-2027. Immunoassays, one of the segments analyzed in the report, is projected to record a 9.1% CAGR and reach US$3.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hybridization segment is readjusted to a revised 9.7% CAGR for the next 7-year period.
The Cancer/Tumor Profiling market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 7.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.
In the global Next Generation Sequencing segment, USA, Canada, Japan, China and Europe will drive the 10.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$864.8 Million in the year 2020 will reach a projected size of US$1.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027.We bring years of research experience to this 8th edition of our report. The 239-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Caris Life Sciences; Genomic Health, Inc.; Helomics Corporation; HTG Molecular Diagnostics, Inc.; Illumina, Inc.; Nanostring Technologies, Inc.; NeoGenomics Laboratories, Inc.; Oxford Gene Technology; Qiagen NV; Ribomed Biotechnologies, Inc.
» Application (Clinical Application, Research Application) » Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancer Types) » Technology (Immunoassays, Hybridization, Next Generation Sequencing, Mass Spectrometry, Other Technologies (Pyrosequencing and Sanger Sequencing))
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Cancer/Tumor Profiling Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Cancer/Tumor Profiling Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Cancer/Tumor Profiling Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 |
| Cancer/Tumor Profiling Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| Immunoassays (Technology) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Immunoassays (Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Immunoassays (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Hybridization (Technology) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Hybridization (Technology) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 |
| Hybridization (Technology) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Next Generation Sequencing (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Next Generation Sequencing (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019 |
| Next Generation Sequencing (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Mass Spectrometry (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Mass Spectrometry (Technology) Market Historic Review by Region/Country in US$ Million: 2012 to 2019 |
| Mass Spectrometry (Technology) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Other Technologies (Technology) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Other Technologies (Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Other Technologies (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Breast Cancer (Cancer Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027 |
| Breast Cancer (Cancer Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019 |
| Breast Cancer (Cancer Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027 |
| Lung Cancer (Cancer Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027 |
| Lung Cancer (Cancer Type) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019 |
| Lung Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Colorectal Cancer (Cancer Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Colorectal Cancer (Cancer Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Colorectal Cancer (Cancer Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Prostate Cancer (Cancer Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Prostate Cancer (Cancer Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 |
| Prostate Cancer (Cancer Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Melanoma Cancer (Cancer Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Melanoma Cancer (Cancer Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019 |
| Melanoma Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Other Cancer Types (Cancer Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Other Cancer Types (Cancer Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019 |
| Other Cancer Types (Cancer Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Clinical Application (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 |
| Clinical Application (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 |
| Clinical Application (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 |
| Research Application (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 |
| Research Application (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 |
| Research Application (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Cancer/Tumor Profiling Market Share (in %) by Company: 2019 & 2025 |
| Cancer/Tumor Profiling Market in US$ Million in the United States by Technology: 2020-2027 |
| United States Cancer/Tumor Profiling Market Retrospective Analysis in US$ Million by Technology: 2012-2019 |
| United States Cancer/Tumor Profiling Market Share Breakdown by Technology: 2012 VS 2020 VS 2027 |
| United States Cancer/Tumor Profiling Market Estimates and Projections in US$ Million by Cancer Type: 2020 to 2027 |
| Cancer/Tumor Profiling Market in the United States by Cancer Type: A Historic Review in US$ Million for 2012-2019 |
| United States Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2012 VS 2020 VS 2027 |
| United States Cancer/Tumor Profiling Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 |
| Cancer/Tumor Profiling Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019 |
| Cancer/Tumor Profiling Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 |
| CANADA |
| Cancer/Tumor Profiling Market Analysis in Canada in US$ Million by Technology: 2020-2027 |
| Cancer/Tumor Profiling Market in Canada: Historic Review in US$ Million by Technology for the Period 2012-2019 |
| Canadian Cancer/Tumor Profiling Market Share Breakdown by Technology: 2012 VS 2020 VS 2027 |
| Canadian Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027 |
| Canadian Cancer/Tumor Profiling Historic Market Review by Cancer Type in US$ Million: 2012-2019 |
| Cancer/Tumor Profiling Market in Canada: Percentage Share Breakdown of Sales by Cancer Type for 2012, 2020, and 2027 |
| Canadian Cancer/Tumor Profiling Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cancer/Tumor Profiling Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Canadian Cancer/Tumor Profiling Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| JAPAN |
| Japanese Medium & Long-Term Outlook for Cancer/Tumor Profiling Market in US$ Million by Technology: 2020-2027 |
| Cancer/Tumor Profiling Market in Japan in US$ Million by Technology: 2012-2019 |
| Japanese Cancer/Tumor Profiling Market Percentage Share Distribution by Technology: 2012 VS 2020 VS 2027 |
| Japanese Market for Cancer/Tumor Profiling: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027 |
| Cancer/Tumor Profiling Market in Japan: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2012-2019 |
| Japanese Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Cancer/Tumor Profiling in US$ Million by Application: 2020 to 2027 |
| Japanese Cancer/Tumor Profiling Market in US$ Million by Application: 2012-2019 |
| Cancer/Tumor Profiling Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 |
| CHINA |
| Cancer/Tumor Profiling Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027 |
| Chinese Cancer/Tumor Profiling Retrospective Market Scenario in US$ Million by Technology: 2012-2019 |
| Cancer/Tumor Profiling Market in China: Percentage Share Analysis by Technology for 2012, 2020, and 2027 |
| Chinese Cancer/Tumor Profiling Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027 |
| Cancer/Tumor Profiling Historic Market Analysis in China in US$ Million by Cancer Type: 2012-2019 |
| Chinese Cancer/Tumor Profiling Market by Cancer Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Demand for Cancer/Tumor Profiling in US$ Million by Application: 2020 to 2027 |
| Cancer/Tumor Profiling Market Review in China in US$ Million by Application: 2012-2019 |
| Chinese Cancer/Tumor Profiling Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| EUROPE |
| Market Facts & Figures |
| European Cancer/Tumor Profiling Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Cancer/Tumor Profiling Market Demand Scenario in US$ Million by Region/Country: 2020-2027 |
| Cancer/Tumor Profiling Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 |
| European Cancer/Tumor Profiling Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Cancer/Tumor Profiling Market Assessment in US$ Million by Technology: 2020-2027 |
| European Cancer/Tumor Profiling Historic Market Review in US$ Million by Technology: 2012-2019 |
| Cancer/Tumor Profiling Market in Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and 2027 |
| European Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027 |
| Cancer/Tumor Profiling Market in Europe in US$ Million by Cancer Type: A Historic Review for the Period 2012-2019 |
| European Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2012 VS 2020 VS 2027 |
| European Cancer/Tumor Profiling Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cancer/Tumor Profiling Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| European Cancer/Tumor Profiling Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| FRANCE |
| French Cancer/Tumor Profiling Market Estimates and Projections in US$ Million by Technology: 2020-2027 |
| French Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Technology: 2012-2019 |
| French Cancer/Tumor Profiling Market Share Breakdown by Technology: 2012 VS 2020 VS 2027 |
| Cancer/Tumor Profiling Market in France by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Cancer/Tumor Profiling Historic Market Scenario in US$ Million by Cancer Type: 2012-2019 |
| French Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2012 VS 2020 VS 2027 |
| Cancer/Tumor Profiling Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027 |
| French Cancer/Tumor Profiling Historic Market Review in US$ Million by Application: 2012-2019 |
| French Cancer/Tumor Profiling Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| GERMANY |
| German Cancer/Tumor Profiling Latent Demand Forecasts in US$ Million by Technology: 2020-2027 |
| Cancer/Tumor Profiling Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2012-2019 |
| German Cancer/Tumor Profiling Market Share Breakdown by Technology: 2012 VS 2020 VS 2027 |
| Cancer/Tumor Profiling Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2020-2027 |
| German Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Cancer Type: 2012-2019 |
| German Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2012 VS 2020 VS 2027 |
| Cancer/Tumor Profiling Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 |
| German Cancer/Tumor Profiling Market in Retrospect in US$ Million by Application: 2012-2019 |
| Cancer/Tumor Profiling Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 |
| ITALY |
| Cancer/Tumor Profiling Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027 |
| Italian Cancer/Tumor Profiling Retrospective Market Scenario in US$ Million by Technology: 2012-2019 |
| Cancer/Tumor Profiling Market in Italy: Percentage Share Analysis by Technology for 2012, 2020, and 2027 |
| Italian Cancer/Tumor Profiling Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027 |
| Cancer/Tumor Profiling Historic Market Analysis in Italy in US$ Million by Cancer Type: 2012-2019 |
| Italian Cancer/Tumor Profiling Market by Cancer Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Demand for Cancer/Tumor Profiling in US$ Million by Application: 2020 to 2027 |
| Cancer/Tumor Profiling Market Review in Italy in US$ Million by Application: 2012-2019 |
| Italian Cancer/Tumor Profiling Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| UNITED KINGDOM |
| United Kingdom Medium & Long-Term Outlook for Cancer/Tumor Profiling Market in US$ Million by Technology: 2020-2027 |
| Cancer/Tumor Profiling Market in the United Kingdom in US$ Million by Technology: 2012-2019 |
| United Kingdom Cancer/Tumor Profiling Market Percentage Share Distribution by Technology: 2012 VS 2020 VS 2027 |
| United Kingdom Market for Cancer/Tumor Profiling: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027 |
| Cancer/Tumor Profiling Market in the United Kingdom: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2012-2019 |
| United Kingdom Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Cancer/Tumor Profiling in US$ Million by Application: 2020 to 2027 |
| United Kingdom Cancer/Tumor Profiling Market in US$ Million by Application: 2012-2019 |
| Cancer/Tumor Profiling Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Cancer/Tumor Profiling Market Assessment in US$ Million by Technology: 2020-2027 |
| Rest of Europe Cancer/Tumor Profiling Historic Market Review in US$ Million by Technology: 2012-2019 |
| Cancer/Tumor Profiling Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and 2027 |
| Rest of Europe Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027 |
| Cancer/Tumor Profiling Market in Rest of Europe in US$ Million by Cancer Type: A Historic Review for the Period 2012-2019 |
| Rest of Europe Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2012 VS 2020 VS 2027 |
| Rest of Europe Cancer/Tumor Profiling Addressable Market Opportunity in US$ Million by Application: 2020-2027 |
| Cancer/Tumor Profiling Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 |
| Rest of Europe Cancer/Tumor Profiling Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Cancer/Tumor Profiling Market Estimates and Projections in US$ Million by Technology: 2020-2027 |
| Asia-Pacific Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Technology: 2012-2019 |
| Asia-Pacific Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Technology: 2012 VS 2020 VS 2027 |
| Cancer/Tumor Profiling Market in Asia-Pacific by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Cancer/Tumor Profiling Historic Market Scenario in US$ Million by Cancer Type: 2012-2019 |
| Asia-Pacific Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2012 VS 2020 VS 2027 |
| Cancer/Tumor Profiling Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027 |
| Asia-Pacific Cancer/Tumor Profiling Historic Market Review in US$ Million by Application: 2012-2019 |
| Asia-Pacific Cancer/Tumor Profiling Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| REST OF WORLD |
| Cancer/Tumor Profiling Market Analysis in Rest of World in US$ Million by Technology: 2020-2027 |
| Cancer/Tumor Profiling Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2012-2019 |
| Rest of World Cancer/Tumor Profiling Market Share Breakdown by Technology: 2012 VS 2020 VS 2027 |
| Rest of World Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027 |
| Rest of World Cancer/Tumor Profiling Historic Market Review by Cancer Type in US$ Million: 2012-2019 |
| Cancer/Tumor Profiling Market in Rest of World: Percentage Share Breakdown of Sales by Cancer Type for 2012, 2020, and 2027 |
| Rest of World Cancer/Tumor Profiling Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 |
| Cancer/Tumor Profiling Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 |
| Rest of World Cancer/Tumor Profiling Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 6 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com